What if you'd held IOVA?
A $1,000 investment in Iovance Biotherapeutics, Inc. (IOVA) at the month-end close of 2010-10 would be worth $79.91 at the close of 2026-09 — -92.0% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $8,730.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2010
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2010 | $1,000 | — |
| 2011 | $800 | -20.0% |
| 2012 | $176 | -78.0% |
| 2013 | $84.00 | -52.3% |
| 2014 | $62.96 | -25.0% |
| 2015 | $61.76 | -1.9% |
| 2016 | $55.60 | -10.0% |
| 2017 | $64.00 | +15.1% |
| 2018 | $70.80 | +10.6% |
| 2019 | $221 | +212.8% |
| 2020 | $371 | +67.6% |
| 2021 | $153 | -58.9% |
| 2022 | $51.12 | -66.5% |
| 2023 | $65.04 | +27.2% |
| 2024 | $59.20 | -9.0% |
| 2025 | $21.84 | -63.1% |
| 2026 | $70.32 | +222.0% |
Best and worst month-end to buy
The best single month-end close to have bought IOVA was 2025-06 ($1.72): $1,000 then is $5,110 today. The worst was 2011-06 ($145): $1,000 then is $60.62.
FAQ
What would $1,000 in IOVA be worth today?
A $1,000 investment in Iovance Biotherapeutics, Inc. (IOVA) at the start of 2010 would be worth about $79.91 today, a total return of -92.0%. Dividends are reinvested in these figures.
What were the best and worst years for IOVA?
Iovance Biotherapeutics, Inc. (IOVA)'s strongest calendar year since 2010 was 2026, a +222.0% return — $1,000 held through that year became about $3,220 by year-end. Its weakest year was 2012, at -78.0%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in IOVA have grown?
Investing $100 at the end of every month since 2010-10 would have grown to about $20,600 on $19,200 invested.
Did IOVA beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $8,730. IOVA trailed the S&P 500 by +99.1% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Iovance Biotherapeutics, Inc. (IOVA) historical total-return data from 2010-10 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.